Hancock Holding Co. grew its position in Colgate-Palmolive Company (NYSE:CL) by 2.3% in the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 3,460 shares of the company’s stock after acquiring an additional 78 shares during the period. Hancock Holding Co.’s holdings in Colgate-Palmolive were worth $256,000 at the end of the most recent quarter.
Several other institutional investors have also recently modified their holdings of CL. Renaissance Technologies LLC raised its position in shares of Colgate-Palmolive by 42.4% in the second quarter. Renaissance Technologies LLC now owns 9,753,400 shares of the company’s stock worth $723,020,000 after acquiring an additional 2,903,800 shares during the period. TIAA CREF Investment Management LLC increased its stake in shares of Colgate-Palmolive by 84.2% during the first quarter. TIAA CREF Investment Management LLC now owns 4,554,989 shares of the company’s stock worth $333,380,000 after purchasing an additional 2,082,262 shares in the last quarter. Vanguard Group Inc. increased its stake in shares of Colgate-Palmolive by 2.4% during the second quarter. Vanguard Group Inc. now owns 67,875,384 shares of the company’s stock worth $5,031,602,000 after purchasing an additional 1,621,392 shares in the last quarter. Parametric Portfolio Associates LLC increased its stake in shares of Colgate-Palmolive by 77.8% during the second quarter. Parametric Portfolio Associates LLC now owns 3,092,033 shares of the company’s stock worth $229,212,000 after purchasing an additional 1,353,177 shares in the last quarter. Finally, Fiera Capital Corp increased its stake in shares of Colgate-Palmolive by 17.3% during the second quarter. Fiera Capital Corp now owns 4,595,453 shares of the company’s stock worth $340,662,000 after purchasing an additional 677,657 shares in the last quarter. Institutional investors and hedge funds own 73.46% of the company’s stock.
In related news, Director Stephen I. Sadove sold 20,780 shares of the company’s stock in a transaction dated Monday, November 6th. The shares were sold at an average price of $70.52, for a total transaction of $1,465,405.60. Following the completion of the sale, the director now owns 36,268 shares of the company’s stock, valued at approximately $2,557,619.36. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, CMO Mukul Deoras sold 7,500 shares of the company’s stock in a transaction dated Friday, November 10th. The shares were sold at an average price of $73.28, for a total transaction of $549,600.00. Following the sale, the chief marketing officer now directly owns 45,217 shares of the company’s stock, valued at approximately $3,313,501.76. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 173,673 shares of company stock valued at $12,629,293. 1.02% of the stock is owned by corporate insiders.
A number of analysts have recently commented on the stock. Zacks Investment Research raised shares of Colgate-Palmolive from a “sell” rating to a “hold” rating in a research note on Wednesday, November 8th. Citigroup Inc. cut their target price on shares of Colgate-Palmolive from $76.00 to $75.00 and set a “neutral” rating for the company in a research note on Thursday, November 2nd. Morgan Stanley cut their target price on shares of Colgate-Palmolive from $84.00 to $83.00 and set an “overweight” rating for the company in a research note on Tuesday, October 31st. Jefferies Group LLC cut their target price on shares of Colgate-Palmolive from $79.00 to $76.00 and set a “hold” rating for the company in a research note on Monday, October 30th. Finally, Stifel Nicolaus set a $73.00 target price on shares of Colgate-Palmolive and gave the stock a “hold” rating in a research note on Sunday, October 29th. One investment analyst has rated the stock with a sell rating, fifteen have issued a hold rating and four have assigned a buy rating to the stock. The stock has an average rating of “Hold” and a consensus price target of $76.67.
Shares of Colgate-Palmolive Company (NYSE:CL) opened at $72.01 on Friday. Colgate-Palmolive Company has a one year low of $63.43 and a one year high of $77.27. The stock has a market cap of $63,232.34, a PE ratio of 25.09, a P/E/G ratio of 3.30 and a beta of 0.80. The company has a debt-to-equity ratio of 24.42, a quick ratio of 0.92 and a current ratio of 1.23.
Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, October 27th. The company reported $0.73 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.73. Colgate-Palmolive had a net margin of 15.10% and a return on equity of 2,782.56%. The company had revenue of $3.97 billion during the quarter, compared to analysts’ expectations of $3.94 billion. During the same quarter in the prior year, the company earned $0.73 EPS. Colgate-Palmolive’s revenue was up 2.8% compared to the same quarter last year. equities analysts expect that Colgate-Palmolive Company will post 2.88 earnings per share for the current year.
The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, November 15th. Investors of record on Monday, October 23rd were paid a dividend of $0.40 per share. The ex-dividend date of this dividend was Friday, October 20th. This represents a $1.60 annualized dividend and a yield of 2.22%. Colgate-Palmolive’s dividend payout ratio is presently 61.78%.
COPYRIGHT VIOLATION NOTICE: “Hancock Holding Co. Has $256,000 Holdings in Colgate-Palmolive Company (CL)” was first reported by Transcript Daily and is the sole property of of Transcript Daily. If you are viewing this report on another site, it was illegally copied and reposted in violation of United States and international copyright and trademark law. The legal version of this report can be read at https://transcriptdaily.com/2017/11/26/hancock-holding-co-has-256000-holdings-in-colgate-palmolive-company-cl.html.
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with MarketBeat.com's FREE daily email newsletter.